147 related articles for article (PubMed ID: 36082627)
21. A Comparative Study of Full-Thickness Blepharotomy Versus Transconjunctival Eyelid Lengthening in the Correction of Upper Eyelid Retraction in Graves' Orbitopathy.
Gonçalves ACP; Nogueira T; Gonçalves ACA; Silva LD; Matayoshi S; Monteiro MLR
Aesthetic Plast Surg; 2018 Feb; 42(1):215-223. PubMed ID: 29026936
[TBL] [Abstract][Full Text] [Related]
22. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method.
Young SM; Kim YD; Lang SS; Woo KI
Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347
[TBL] [Abstract][Full Text] [Related]
23. [Acellular xenogenic dermal matrix as a spacer graft for treatment of eyelid retraction related to thyroid associated ophthalmopathy].
Zhuang A; Sun J; Zhang S; Zhou HF
Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):821-827. PubMed ID: 31715678
[No Abstract] [Full Text] [Related]
24. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
[TBL] [Abstract][Full Text] [Related]
25. The Injection for the Lower Eyelid Retraction: A Mechanical Analysis of the Lifting Effect of the Hyaluronic Acid.
Xi W; Han S; Feng S; Li K; Brunetti B; Lazzeri D; Tong Y; Zhang Y
Aesthetic Plast Surg; 2019 Oct; 43(5):1310-1317. PubMed ID: 31399822
[TBL] [Abstract][Full Text] [Related]
26. Transconjunctival Müller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy.
Ben Simon GJ; Mansury AM; Schwarcz RM; Modjtahedi S; McCann JD; Goldberg RA
Am J Ophthalmol; 2005 Jul; 140(1):94-9. PubMed ID: 15939390
[TBL] [Abstract][Full Text] [Related]
27. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.
Xu D; Liu Y; Xu H; Li H
Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849
[TBL] [Abstract][Full Text] [Related]
28. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.
Lee JM; Lee H; Park M; Baek S
J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303
[TBL] [Abstract][Full Text] [Related]
29. A modified posterior approach for upper eyelid retraction.
Looi AL; Sharma B; Dolman PJ
Ophthalmic Plast Reconstr Surg; 2006; 22(6):434-7. PubMed ID: 17117096
[TBL] [Abstract][Full Text] [Related]
30. Stability of eyelid height after graded anterior-approach lid lowering for dysthyroid upper lid retraction.
Shortt AJ; Bhogal M; Rose GE; Shah-Desai S
Orbit; 2011 Dec; 30(6):280-8. PubMed ID: 22132845
[TBL] [Abstract][Full Text] [Related]
31. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results.
Ozturk Karabulut G; Fazil K; Saracoglu Yilmaz B; Ozturker C; Günaydın ZK; Taskapili M; Kaynak P
Orbit; 2021 Oct; 40(5):381-388. PubMed ID: 32885692
[TBL] [Abstract][Full Text] [Related]
32. Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease.
Al-Sharif EM; Zhou J; Shoji MK; Acuff K; Liu CY; Korn BS; Kikkawa DO
Ophthalmic Plast Reconstr Surg; 2024 May; ():. PubMed ID: 38722772
[TBL] [Abstract][Full Text] [Related]
33. A single transcutaneous injection with Botox for dysthyroid lid retraction.
Shih MJ; Liao SL; Lu HY
Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
[TBL] [Abstract][Full Text] [Related]
34. Lowering of the High Eyelid Crease in Revision Upper Eyelid Surgery.
Young SM; Kim YD; Kim JH; Lang SS; Woo KI
Aesthetic Plast Surg; 2019 Feb; 43(1):139-146. PubMed ID: 30276454
[TBL] [Abstract][Full Text] [Related]
35. Upper Eyelid Retraction in Graves' Ophthalmopathy: Our Surgical Experience on 153 Cases of Full-Thickness Anterior Blepharotomy with Mullerectomy.
Guastella C; di Furia D; Torretta S; Ibba TM; Pignataro L; Accorona R
Aesthetic Plast Surg; 2022 Aug; 46(4):1713-1721. PubMed ID: 35129648
[TBL] [Abstract][Full Text] [Related]
36. Use of hyaluronic Acid gel in the management of paralytic lagophthalmos: the hyaluronic Acid gel "gold weight".
Mancini R; Taban M; Lowinger A; Nakra T; Tsirbas A; Douglas RS; Shorr N; Goldberg RA
Ophthalmic Plast Reconstr Surg; 2009; 25(1):23-6. PubMed ID: 19273918
[TBL] [Abstract][Full Text] [Related]
37. A Promising Modified Procedure for Upper Eyelid Retraction-Associated Graves' Ophthalmopathy: Transconjunctival Lateral Levator Aponeurectomy.
Khatavi F; Nasrollahi K; Zandi A; Panahi M; Mortazavi M; Pourazizi M; Ranjbar-Omidi B
Med Hypothesis Discov Innov Ophthalmol; 2017; 6(2):44-48. PubMed ID: 29367934
[TBL] [Abstract][Full Text] [Related]
38. Influence of surgical approach for decompression on lower eyelid position in thyroid eye disease.
Thorne AW; Rootman DB
Orbit; 2020 Apr; 39(2):84-86. PubMed ID: 31021263
[No Abstract] [Full Text] [Related]
39. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections.
Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823
[TBL] [Abstract][Full Text] [Related]
40. Effect of double-fold surgery on spontaneous resolution of Graves' upper eyelid retraction.
Kim DK; Choi M; Yoon JS
Can J Ophthalmol; 2015 Feb; 50(1):49-53. PubMed ID: 25677283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
